Addition of X4P-001 to Nivolumab Treatment in Participants With Renal Cell Carcinoma
Clinical trial NCT02923531 · TERMINATED
Trial details
- NCT number
- NCT02923531
- Sponsor
- X4 Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-12-07
- Primary completion
- 2018-08-08
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.